Staffing Solution Part of PDI ON DEMAND Suite of Innovative Sales
Services
SADDLE RIVER, N.J.--(BUSINESS WIRE)--April 30, 2007--PDI, Inc. (NASDAQ:PDII), a provider of commercialization services to the biopharmaceutical industry, today announced that its Talent Acquisition business unit has been selected to recruit a sales team consisting of up to 60 specialty representatives and five managers for a global healthcare products leader by the end of the second quarter.
Susanne P. Reilly, Ph.D., Vice President of Talent Management at PDI, said, "We are very excited to have been selected to partner with this client. We believe we were awarded this critical assignment based on our proven expertise in efficiently providing top talent to industry-leading companies, our award-winning time-to-fill rates, and the performance results of the talent we have recruited over the past two decades. Each phase of our process is coordinated to optimize the end result: selecting highly successful and motivated candidates who become long term assets for their sales team." Utilizing best practice research and methodology, the PDI Talent Acquisition team has been recognized as an industry leader in recruiting and hiring outstanding sales professionals.
Michael Marquard, PDI's CEO, commented, "We are very pleased to have been chosen to address this new client's staffing needs and are energized by the prospect of building a long-standing and mutually beneficial relationship. Additionally, this reinforces our strategy of providing stand-alone talent acquisition services and meeting the growing demand for the flexible and innovative solutions offered under our PDI ON DEMAND suite of products."
About PDI
PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing and commercialization expertise; and a philosophy of performance.
PDI operates in two areas, Sales Services and Marketing Services. Our Sales Services include Performance Sales Teams(TM), which are dedicated teams for specific customers; Select Access(TM), our targeted sales solution that leverages an existing infrastructure; and PDI ON DEMAND, innovative sales services that provide rapid, customized sales force solutions tailored to meet local, regional, and seasonal needs. Our Marketing Services include marketing research and consulting services through TVG in Dresher, PA., and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high-quality provider of ACCME-accredited continuing medical education through Vital Issues in Medicine (VIM(R)), located in Dresher, PA. PDI's experience extends across multiple therapeutic categories and includes office and hospital based initiatives.
PDI's commitment is to deliver innovative solutions, unparalleled execution and superior results for its customers. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to retaining the industry's highest-quality employees. For more information, please visit the Company's website at www.pdi-inc.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, the termination of or material reduction in the size of any of our customer contracts, the loss by our or our customers' intellectual property rights, our ability or inability to secure new business to offset the recent loss of customer contracts and the terms of any replacement business we secure, changes in our operating expenses, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of any stock repurchase programs, the adequacy of the reserves PDI has taken, the financial viability of certain companies whose debt and equity securities we hold, the outcome of certain litigation, PDI's ability to implement its current and future business plans, and the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2006, and PDI's subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
CONTACT: PDI, Inc.
Jeff Smith, Chief Financial Officer
201-258-8451
JESmith@pdi-inc.com
www.pdi-inc.com
or
Investor Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
Bruce Voss, 310-691-7100
bvoss@lhai.com